New Delhi [India], July 30: A new study, entitled TOPSPIN, coordinated by the Centre for Chronic Disease Control (CCDC) New Delhi, in collaboration with the All India Institute of Medical Sciences (AIIMS) New Delhi, and Imperial College London, examined 1,981 patients with uncontrolled hyper
New Delhi [India], November 19: The Centre for Chronic Disease Control (CCDC) announced the completion of the Treatment Optimization for Blood Pressure with Single-Pill Combinations in India (TOPSPIN) Study, a research initiative that tested the effectiveness of three double anti-hypertensiv
Men appeared to experience greater rates of severe sickness and mortality at the beginning of the COVID pandemic, which led researchers to hypothesise a connection between androgen receptors—which bind to hormones like testosterone—and SARS-CoV-2 virus infection
A study discovered that when ribociclib, a targeted therapy medicine, is added to hormone treatment, patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a substantial invasive disease-free survival advantage.
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.